Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 33.20180.22-67.21-38.59-

What is the latest EBIT Growth ratio of PIRAMAL PHARMA ?

The latest EBIT Growth ratio of PIRAMAL PHARMA is 33.20 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202533.20
Mar2024180.22
Mar2023-67.21
Mar2022-38.59
Mar2021-

How is EBIT Growth of PIRAMAL PHARMA Trending?

Years EBIT Growth % Change
Mar2025 33.2
-81.58
Mar2024 180.22
Positive
Mar2023 -67.21
Negative
Mar2022 -38.59
0
Mar2021 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare EBIT Growth ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹22,981.9 Cr -2.7% -7.3% -31.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,086.0 Cr -1.5% -4.8% -4.2% Stock Analytics
DIVIS LABORATORIES ₹169,616.0 Cr -1.9% -1.6% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,361.0 Cr 0.3% 1.6% 12.1% Stock Analytics
CIPLA ₹120,713.0 Cr -1.2% -2% 2% Stock Analytics
DR REDDYS LABORATORIES ₹105,881.0 Cr -1.2% 1.5% -6.1% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-2.7%

-7.3%

-31.8%

SENSEX

-0.3%

-1.1%

7.8%


You may also like the below Video Courses